You are a biotech company that has just been granted a patent connected with drug discovery. What do you do with it? The costs of drug discovery and development are so prohibitive that only large companies have sufficient resources to proceed with such an undertaking. Therefore most biotech companies will need to involve a larger third party at some stage in order to develop the product and get it to market. When should your average biotech company try to tie the knot with a big pharma partner?
Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kempton, L. What to do with your granted patent. Nat Rev Drug Discov 3, 991 (2004). https://doi.org/10.1038/nrd1584
Issue date:
DOI: https://doi.org/10.1038/nrd1584
